Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ultra Nasdaq Biotech Proshares (BIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund basics

See More
  • Fund Family ProShares
  • Assets Under Management 375,211,000
  • Shares Outstanding, K 6,100
  • Annual Dividend Yield 0.00%
  • Price/Earnings ttm 15.17
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.30 +11.82%
on 05/29/18
61.59 -3.23%
on 06/20/18
+5.46 (+10.08%)
since 05/22/18
3-Month
48.12 +23.86%
on 05/03/18
61.59 -3.23%
on 06/20/18
+3.16 (+5.60%)
since 03/22/18
52-Week
48.12 +23.86%
on 05/03/18
69.62 -14.39%
on 01/29/18
+2.58 (+4.52%)
since 06/22/17

Most Recent Stories

More News
3 ETFs to Watch on Biotech Earnings

Major Biotech companies report mixed Q4 results.

IBB : 112.23 (-0.34%)
BBH : 122.09 (+0.04%)
BIB : 59.60 (-0.78%)
GILD : 71.07 (-0.63%)
AMGN : 185.15 (-0.45%)
ALXN : 127.57 (+1.40%)
BIIB : 296.04 (-0.44%)
3 ETFs to Watch on Biotech Earnings

Major Biotech companies report mixed Q4 results.

IBB : 112.23 (-0.34%)
BBH : 122.09 (+0.04%)
BIB : 59.60 (-0.78%)
GILD : 71.07 (-0.63%)
AMGN : 185.15 (-0.45%)
ALXN : 127.57 (+1.40%)
BIIB : 296.04 (-0.44%)
3 ETFs to Watch on Biotech Earnings

Major Biotech companies report mixed Q3 results.

IBB : 112.23 (-0.34%)
BBH : 122.09 (+0.04%)
BIB : 59.60 (-0.78%)
GILD : 71.07 (-0.63%)
AMGN : 185.15 (-0.45%)
ALXN : 127.57 (+1.40%)
BIIB : 296.04 (-0.44%)
3 ETFs to Watch on Biotech Earnings

Major Biotech companies report mixed Q3 results.

IBB : 112.23 (-0.34%)
BBH : 122.09 (+0.04%)
BIB : 59.60 (-0.78%)
GILD : 71.07 (-0.63%)
AMGN : 185.15 (-0.45%)
ALXN : 127.57 (+1.40%)
BIIB : 296.04 (-0.44%)
Should You Keep Your Portfolio Healthy with Biotech ETFs?

Biotech ETFs are riding high on research and developments and FDA approvals.

BBC : 34.27 (-0.49%)
CNCR : 25.65 (-0.54%)
IBB : 112.23 (-0.34%)
VRTX : 159.19 (+1.67%)
BBH : 122.09 (+0.04%)
LABU : 107.75 (-0.06%)
K : 67.40 (+0.84%)
BBP : 45.46 (+0.38%)
SBIO : 38.82 (+0.15%)
UBIO : 35.45 (-1.06%)
CLVS : 48.65 (+2.79%)
BIB : 59.60 (-0.78%)
GILD : 71.07 (-0.63%)
SPY : 274.74 (+0.18%)
XBI : 99.08 (+0.02%)
Should You Keep Your Portfolio Healthy with Biotech ETFs?

Biotech ETFs are riding high on research and developments and FDA approvals.

BBC : 34.27 (-0.49%)
CNCR : 25.65 (-0.54%)
IBB : 112.23 (-0.34%)
VRTX : 159.19 (+1.67%)
BBH : 122.09 (+0.04%)
LABU : 107.75 (-0.06%)
K : 67.40 (+0.84%)
BBP : 45.46 (+0.38%)
SBIO : 38.82 (+0.15%)
UBIO : 35.45 (-1.06%)
CLVS : 48.65 (+2.79%)
BIB : 59.60 (-0.78%)
GILD : 71.07 (-0.63%)
SPY : 274.74 (+0.18%)
XBI : 99.08 (+0.02%)
3 ETFs to Watch Out for on Biotech Earnings

Major players in the biotech space reported their second quarter 2017 results.

IBB : 112.23 (-0.34%)
BBH : 122.09 (+0.04%)
BIB : 59.60 (-0.78%)
GILD : 71.07 (-0.63%)
AMGN : 185.15 (-0.45%)
ALXN : 127.57 (+1.40%)
BIIB : 296.04 (-0.44%)
3 ETFs to Watch Out for on Biotech Earnings

Major players in the biotech space reported their second quarter 2017 results.

IBB : 112.23 (-0.34%)
BBH : 122.09 (+0.04%)
BIB : 59.60 (-0.78%)
GILD : 71.07 (-0.63%)
AMGN : 185.15 (-0.45%)
ALXN : 127.57 (+1.40%)
BIIB : 296.04 (-0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BIB with:

Fund Summary

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the NASDAQ Biotechnology Index.

See More

Top 10 Holdings

Name % Holdings
iShares Biotech (IBB) SWAP Bank of America NA 0.00%
iShares Biotech (IBB) SWAP Morgan Stanley & Co. International PLC 0.00%
NASDAQ Biotechnology Index SWAP Bank of America NA 0.00%
NASDAQ Biotechnology Index SWAP Citibank NA 0.00%
NASDAQ Biotechnology Index SWAP Credit Suisse International 0.00%
NASDAQ Biotechnology Index SWAP Deutsche Bank AG 0.00%
NASDAQ Biotechnology Index SWAP Goldman Sachs International 0.00%
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC 0.00%
NASDAQ Biotechnology Index SWAP Societe Generale 0.00%
NASDAQ Biotechnology Index SWAP UBS AG 0.00%

See More

Key Turning Points

2nd Resistance Point 61.07
1st Resistance Point 60.34
Last Price 59.60
1st Support Level 59.05
2nd Support Level 58.49

See More

52-Week High 69.62
Fibonacci 61.8% 61.41
Last Price 59.60
Fibonacci 50% 58.87
Fibonacci 38.2% 56.33
52-Week Low 48.12

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar